Correlation Between Pantech Group and Duopharma Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pantech Group and Duopharma Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pantech Group and Duopharma Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pantech Group Holdings and Duopharma Biotech Bhd, you can compare the effects of market volatilities on Pantech Group and Duopharma Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pantech Group with a short position of Duopharma Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pantech Group and Duopharma Biotech.

Diversification Opportunities for Pantech Group and Duopharma Biotech

-0.22
  Correlation Coefficient

Very good diversification

The 3 months correlation between Pantech and Duopharma is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding Pantech Group Holdings and Duopharma Biotech Bhd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Duopharma Biotech Bhd and Pantech Group is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pantech Group Holdings are associated (or correlated) with Duopharma Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Duopharma Biotech Bhd has no effect on the direction of Pantech Group i.e., Pantech Group and Duopharma Biotech go up and down completely randomly.

Pair Corralation between Pantech Group and Duopharma Biotech

Assuming the 90 days trading horizon Pantech Group Holdings is expected to generate 0.6 times more return on investment than Duopharma Biotech. However, Pantech Group Holdings is 1.65 times less risky than Duopharma Biotech. It trades about 0.23 of its potential returns per unit of risk. Duopharma Biotech Bhd is currently generating about -0.23 per unit of risk. If you would invest  93.00  in Pantech Group Holdings on August 27, 2024 and sell it today you would earn a total of  3.00  from holding Pantech Group Holdings or generate 3.23% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Pantech Group Holdings  vs.  Duopharma Biotech Bhd

 Performance 
       Timeline  
Pantech Group Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pantech Group Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Pantech Group is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.
Duopharma Biotech Bhd 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Duopharma Biotech Bhd are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent basic indicators, Duopharma Biotech is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.

Pantech Group and Duopharma Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pantech Group and Duopharma Biotech

The main advantage of trading using opposite Pantech Group and Duopharma Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pantech Group position performs unexpectedly, Duopharma Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Duopharma Biotech will offset losses from the drop in Duopharma Biotech's long position.
The idea behind Pantech Group Holdings and Duopharma Biotech Bhd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance